Palantir (PLTR) faces fresh valuation test as investor says “too early to call” despite Truist’s $223 target
Palantir Technologies’ rally is hitting a familiar snag: the stock price. Billy Duberstein, a “five-star” investor, said it’s “too early to call” whether the recent slump—shares have dropped about 14% since the November third-quarter report—signals a cooling off. He described the valuation as “frothy” but noted, “The seemingly insane valuation might not be as crazy as it seems if Palantir can continue to deliver the blockbuster growth it did in 2025.” Duberstein added, “Only time will tell if the AI revolution can continue propelling Palantir to new heights, or if the company’s growth will inevitably stall out.”
